Aurobindo Pharma Ltd.

Financial

	Aurobindo Pharma	Glenmark Pharma	Alkem Laboratories
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	861.0 .	13.0 .	185.0 .
Number of ANDA's Approved By USFDA	719.0 .	25.0 .	158.0 .
US DMF Filings	309.0 .	n/a	n/a
Europe DMF Filings	2096.0 .	n/a	n/a
R&D as a % of Total Sales	5.05 %	7.3 %	5.0 %
Financials
5 yr Average ROE	13.97 %	4.18 %	17.38 %
5yr average Equity Multiplier	1.51	1.88	1.39
5yr Average Asset Turnover Ratio	0.71	0.79	0.86
5yr Avg Net Profit Margin	12.77 %	2.73 %	14.54 %
Price to Book	2.0	6.84	5.01
P/E	18.7	57.79	27.71
5yr Avg Cash Conversion Cycle	-49.62 Days	-121.67 Days	-61.46 Days
Inventory Days	59.48 Days	40.44 Days	56.11 Days
Days Receivable	28.34 Days	36.38 Days	44.62 Days
Days Payable	115.71 Days	201.37 Days	122.42 Days
5yr Average Interest Coverage Ratio	43.78	3.48	24.48
5yr Avg ROCE	16.69 %	16.29 %	22.76 %
5yr Avg Operating Profit Margin	19.28 %	15.62 %	18.44 %
5 yr average Debt to Equity	0.21	0.49	0.18
5yr CAGR Net Profit	2.21 %	n/a	6.44 %
5yr Average Return on Assets	9.18 %	1.86 %	12.47 %
Shareholdings
Promoter Holding	51.82 %	46.65 %	53.04 %
Share Pledged by Promoters	17.08 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.01 %	0.0	-4.1 %
Change in Mutual Fund Holding (3 Yrs)	9.14 %	9.74 %	8.82 %

Business

	Aurobindo Pharma	Glenmark Pharma	Alkem Laboratories
Product Wise Break-Up	Product Wise Break-Up Formulations 87.25 Active Pharmaceutical Ingredient (API) 12.75 Glenmark Pharma (Branded generics) 0 Glenmark generics 0 Pharmaceutical 0	Product Wise Break-Up Pharmaceutical 0 Formulations 39.54 Branded Generics 60.46 Formulations 0 Active Pharmaceutical Ingredient (API) 0	Product Wise Break-Up Pharmaceutical 100.0 Glenmark generics 0 Glenmark Pharma (Branded generics) 0 Formulations 0 Active Pharmaceutical Ingredient (API) 0
Location Wise Break-Up	Location Wise Break-Up USA 48.6 Europe 25.6 Rest of the World 15.8 India 10.0 Latin America 0 North America 0	Location Wise Break-Up Latin America 0 Europe 22.5 North America 21.9 India 29.0 USA 0 Rest of the World 24.3 Others 2.3	Location Wise Break-Up Latin America 0 Europe 0 North America 0 India 68.66 USA 31.34 Rest of the World 0
Asset Break-Up	Asset Break-Up India 65.36 USA 18.29 Europe 8.08 Rest of the World 0 Latin America 0 North America 0 Others 8.27	Asset Break-Up Latin America 6.22 Europe 3.35 North America 40.3 India 50.13 USA 0 Rest of the World 0	Asset Break-Up Latin America 0 Europe 0 North America 0 India 70.19 USA 28.27 Rest of the World 0 Others 1.54